Publications
161
Citations
116,171
Est. group size
~6
Recurring co-author estimate
Active years
21
Publishing since 2006
This researcher studies schizophrenia and psychosis, with a focus on early detection and treatment of first-episode and clinical high-risk psychosis, mental health service access, and large-scale multi-site research infrastructure such as the Accelerating Medicines Partnership Schizophrenia Program. Their work spans clinical psychiatry, digital health tools, neuroimaging, and cognitive assessment, and also includes contributions to global disease burden studies. Prospective students would likely engage with large collaborative datasets, standardized clinical measures, and questions about mental health care delivery and outcomes.
Publication output has fluctuated over the past decade, with a notable dip in 2019 and 2022 followed by a sharp increase in 2025, suggesting variable but currently active and growing productivity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Incidence of First-Episode Psychosis Among Privately Insured Individuals
Psychiatric Services · 2026
- Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
The Lancet · 2025
- Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
The Lancet · 2025
- Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program
Schizophrenia · 2025
- Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample
Schizophrenia · 2025
- The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program
Schizophrenia · 2025
- The electroencephalography protocol for the Accelerating Medicines Partnership® Schizophrenia Program: Reliability and stability of measures
Schizophrenia · 2025
- Stepped Care Interventions for Psychosis Risk: Findings From Clinical High Risk for Psychosis Grantee Programs
Psychiatric Services · 2025
- Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative
Schizophrenia · 2025
- Sample Ascertainment and Recruitment Sources in the Accelerating Medicines Partnership Schizophrenia Program
Schizophrenia Bulletin Open · 2025
- Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program
Schizophrenia Bulletin Open · 2025
- Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative
UNC Libraries · 2025
- The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program
UNC Libraries · 2025
- Baseline Clinical Characterization of Participants in the Accelerating Medicines Partnership Schizophrenia Program
UNC Libraries · 2025
- Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample
UNC Libraries · 2025
- The Lancet×28
- Early Intervention in Psychiatry×11
- UNC Libraries×11
- Schizophrenia×6
- Psychiatric Services×6
- Edwin Lee
Medicine · The Ohio State University
- Mahogany A. Monette
Medicine · Indiana University
- Aubrey M. Moe
Medicine · The Ohio State University
- Jenifer L. Vohs
Medicine · Indiana University
- Christi L. Trask
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile